TECH
Bio-Techne Corp
72.60$
+0.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 33.1% | 35.2% | 32.6% | 33.6% | 36.8% | 34.7% | 32.1% | 37.3% | 34.4% | 35.4% | 33.1% | 34.2% | 34.2% | |
| 66.9% | 64.8% | 67.4% | 66.4% | 63.2% | 65.3% | 67.9% | 62.7% | 65.6% | 64.6% | 66.9% | 65.8% | 65.8% | |
| 8.7% | 8.4% | 8.5% | 7.8% | 8.2% | 8.4% | 7.8% | 8.2% | 8.5% | 7.8% | 7.5% | 7.5% | 7.8% | |
| 38.0% | 42.4% | 36.9% | 20.9% | 41.2% | 40.9% | 47.8% | 7.3% | 40.6% | 38.4% | 35.1% | 35.2% | 37.2% | |
| 46.7% | 50.8% | 45.3% | 51.5% | 49.4% | 49.3% | 55.6% | 70.3% | 49.0% | 46.2% | 42.6% | 42.7% | 45.0% | |
| 20.2% | 13.9% | 22.1% | 15.0% | 13.8% | 16.0% | 12.2% | -7.5% | 16.6% | 18.4% | 24.2% | 23.1% | 20.7% | |
| 1.8% | 1.6% | 1.3% | 0.8% | 0.8% | 0.7% | 0.6% | 0.7% | 1.0% | 0.7% | 1.0% | 0.9% | 0.9% | |
| 17.9% | 12.2% | 20.1% | 13.6% | 13.9% | 14.4% | 12.1% | -7.2% | 16.7% | 17.2% | 22.9% | 22.0% | 19.8% | |
| -0.5% | 2.2% | 4.0% | 0.4% | 2.3% | 2.7% | 5.0% | -1.6% | 3.4% | 4.3% | 6.5% | 5.0% | 4.8% | |
| 18.4% | 10.1% | 16.2% | 13.3% | 11.6% | 11.7% | 7.1% | -5.6% | 13.3% | 12.8% | 16.4% | 17.0% | 15.0% | |
| 30.0% | 24.0% | 30.5% | 23.6% | 24.4% | 24.3% | 21.5% | 2.0% | 26.3% | 26.2% | 31.7% | 28.6% | 28.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.